A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057)

NCT00414050 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1718

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: Modified Process Hepatitis B Vaccine (Experimental)
BIOLOGICAL: Hepatitis B Vaccine (Recombinant)
BIOLOGICAL: Hepatitis B Vaccine (Recombinant)

Sponsor

Merck Sharp & Dohme LLC